主页文献库搜索
The Akt inhibitor MK2206 synergizes, but perifosine antagonizes, the BRAF(V60...

Liu(Ruixin),Liu(Dingxie),Xing(Mingzhao) J Clin Endocrinol Metab 2012-04-09

...PIK3CA mutations.,We found that MK2206 could potently, when used alone, and synergistically, when combined with either P...

Ran is a potential therapeutic target for cancer cells with molecular changes...

Yuen(Hiu-Fung),Chan(Ka-Kui),Grills(Claire)... Clin Cancer Res 2012-08-01

...PIK3CA, all of which are mutations that potentially correlate with activation of the PI3K/Akt/mTORC1 and/or Ras/MEK/ERK ...

Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rat...

Chaft(Jamie E),Arcila(Maria E),Paik(Paul K... Mol Cancer Ther 2012-06-18

...PIK3CA) encodes the p110α subunit of the mitogenic signaling protein phosphoinositide 3-kinase (PI3K). PIK3CA mutations ...

Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility ...

Wang(Li-E),Ma(Hongxia),Hale(Katherine S),Y... J Cancer Res Clin Oncol 2012-04-16

...PIK3CA rs2699887) showed significant associations with survival of endometrial cancer patients. (3) KRAS rs7312175 and P...

BIM expression in treatment-naive cancers predicts responsiveness to kinase i...

Faber(Anthony C),Corcoran(Ryan B),Ebi(Hiro... Cancer Discov 2012-11-21

...PIK3CA-mutant cancers, respectively, but BIM levels did not predict responsiveness to standard chemotherapies. Furthermo...

[Molecular predictive markers of EGFR-targeted therapy in metastatic colorect...

Fabian(P),Berkovcová(J) Cesk Patol 2012-01-12

...PIK3CA oncogenes, or inactivation of the PTEN tumor supressor gene is central to the progression of colorectal cancer. T...

The novel chemical entity YTR107 inhibits recruitment of nucleophosmin to sit...

Sekhar(Konjeti R),Reddy(Yerramreddy Thirup... Clin Cancer Res 2012-02-03

...PIK3CA, and/or BRAF oncogenes. Affinity-based solid-phase resin capture followed by liquid chromatography/tandem mass sp...

PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer...

Fariña Sarasqueta(Arantza),Zeestraten(Elia... Cell Oncol (Dordr) 2012-05-29

...PIK3CA mutations in exons 9 and 20 by single nucleotide primer extension (N = 428) or by real time PCR (N = 257).,PIK3CA...

A phase I trial of liposomal doxorubicin, bevacizumab, and temsirolimus in pa...

Moroney(John W),Schlumbrecht(Matthew P),He... Clin Cancer Res 2012-01-20

...PIK3CA, BRAF, KRAS, and immunhistochemistry for PTEN loss were conducted.,This article details 74 patients with gynecolo...

Mutational characterization of individual breast tumors: TP53 and PI3K pathwa...

Boyault(Sandrine),Drouet(Youenn),Navarro(C... Breast Cancer Res Treat 2012-05-22

...PIK3CA, PTEN, CDH1, and AKT1 were screened in each of 120 human primary breast tumors. Mutations in at least one of thes...

上一页 227 228 229 230 231 232 233 234 235 下一页 231 / 共 353

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com